The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today?
Open accessAbstract
Skin cancers are the most frequent malignancies in organ transplant recipients (OTR), with 95% being nonmelanoma skin cancers (NMSC), especially squamous (SCC) and basal cell carcinomas. Most OTR with a first SCC subsequently develop multiple NMSC within 5 years, highlighting the concept of 'field cancerization', and are also at high risk for noncutaneous cancers. In order to reduce the tumor burden in these patients, their management requires an interdisciplinary approach including revision of immunosuppression, new dermatological treatments and adequate education about photoprotection in specialized dermatology clinics for OTR. Whereas surgery remains the gold-standard therapy for NMSC, noninvasive methods have shown promising results to treat superficial keratoses and subclinical lesions on large body areas. Although the threshold of skin cancer necessitating revision of immunosuppression is debated, this measure should be envisaged at the occurrence of the first SCC, or in case of multiple non-SCC NMSC. While the role of immunosuppressants in the occurrence of NMSC is widely recognized, the best immunosuppressive strategies remain to be defined. Presently, randomized prospective studies assess the burden of new skin tumors, as well as graft and patient survival, in patients with one or several NMSC after the introduction of mTOR (mammalian target of rapamycin) inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Self-citationCancer after Kidney Transplantation in the United States
Kasiske, B. L., Snyder, J. J., Gilbertson, D. T., & Wang, C. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00450.x · Cited by 1,071
Dantal, J., Hourmant, M., Cantarovich, D., Giral, M., Blancho, G., Dreno, B., & Soulillou, J.-P. (1998) · The Lancet · doi:10.1016/s0140-6736(97)08496-1 · Cited by 745
Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage
O'Donovan, P., Perrett, C. M., Zhang, X., Montaner, B., Xu, Y.-Z., Harwood, C. A., McGregor, J. M., Walker, S. L., Hanaoka, F., & Karran, P. (2005) · Science · doi:10.1126/science.1114233 · Cited by 631
Kauffman, H. M., Cherikh, W. S., Cheng, Y., Hanto, D. W., & Kahan, B. D. (2005) · Transplantation · doi:10.1097/01.tp.0000184006.43152.8d · Cited by 621
Campistol, J. M., Eris, J., Oberbauer, R., Friend, P., Hutchison, B., Morales, J. M., Claesson, K., Stallone, G., Russ, G., Rostaing, L., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090993 · Cited by 478
PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION
Guba, M., Graeb, C., Jauch, K.-W., & Geissler, E. K. (2004) · Transplantation · doi:10.1097/01.tp.0000120181.89206.54 · Cited by 360
Mathew, T., Kreis, H., & Friend, P. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00188.x · Cited by 307
Bordea, C., Wojnarowska, F., Millard, P. R., Doll, H., Welsh, K., & Morris, P. J. (2004) · Transplantation · doi:10.1097/01.tp.0000108491.62935.df · Cited by 247
Cutaneous Adverse Events in Renal Transplant Recipients Receiving Sirolimus-Based Therapy1
Mah??, E., Morelon, E., Lechaton, S., Sang, K.-H. L. Q., Mansouri, R., Ducasse, M.-F., Mamzer-Bruneel, M.-F., de Prost, Y., Kreis, H., & Bodemer, C. (2005) · Transplantation · doi:10.1097/01.tp.0000151630.25127.3a · Cited by 228
Cited by
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Euvrard, S., Morelon, E., Rostaing, L., Goffin, E., Brocard, A., Tromme, I., Broeders, N., del Marmol, V., Chatelet, V., Dompmartin, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204166 · Cited by 593
Self-citationImmune cell dysfunction and inflammation in end-stage renal disease
Betjes, M. G. H. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.44 · Cited by 542
Ulrich, C., Jürgensen, J. S., Degen, A., Hackethal, M., Ulrich, M., Patel, M. J., Eberle, J., Terhorst, D., Sterry, W., & Stockfleth, E. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09453.x · Cited by 346
Self-citationImmunology of the ageing kidney
Sato, Y., & Yanagita, M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0185-9 · Cited by 126
Willey, A., Mehta, S., & Lee, P. K. (2010) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2009.01384.x · Cited by 124
Metadata
- Authors
- Ulrich, C., Kanitakis, J., Stockfleth, E., & Euvrard, S.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 8
- Issue
- 11
- Pages
- 2192-2198
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2067453004
- Cited by
- 278
- References
- 31
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today? https://app.cochat.ai/papers/10.1111/j.1600-6143.2008.02386.x
- The paper
- Ulrich, C., Kanitakis, J., Stockfleth, E., & Euvrard, S. (2008). Skin Cancer in Organ Transplant Recipients—Where Do We Stand Today? American Journal of Transplantation. https://doi.org/10.1111/j.1600-6143.2008.02386.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.